Cargando…

Engineering a niche supporting hematopoietic stem cell development using integrated single-cell transcriptomics

Hematopoietic stem cells (HSCs) develop from hemogenic endothelium within embryonic arterial vessels such as the aorta of the aorta-gonad-mesonephros region (AGM). To identify the signals responsible for HSC formation, here we use single cell RNA-sequencing to simultaneously analyze the transcriptio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadland, Brandon, Varnum-Finney, Barbara, Dozono, Stacey, Dignum, Tessa, Nourigat-McKay, Cynthia, Heck, Adam M., Ishida, Takashi, Jackson, Dana L., Itkin, Tomer, Butler, Jason M., Rafii, Shahin, Trapnell, Cole, Bernstein, Irwin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948249/
https://www.ncbi.nlm.nih.gov/pubmed/35332125
http://dx.doi.org/10.1038/s41467-022-28781-z
Descripción
Sumario:Hematopoietic stem cells (HSCs) develop from hemogenic endothelium within embryonic arterial vessels such as the aorta of the aorta-gonad-mesonephros region (AGM). To identify the signals responsible for HSC formation, here we use single cell RNA-sequencing to simultaneously analyze the transcriptional profiles of AGM-derived cells transitioning from hemogenic endothelium to HSCs, and AGM-derived endothelial cells which provide signals sufficient to support HSC maturation and self-renewal. Pseudotemporal ordering reveals dynamics of gene expression during the hemogenic endothelium to HSC transition, identifying surface receptors specifically expressed on developing HSCs. Transcriptional profiling of niche endothelial cells identifies corresponding ligands, including those signaling to Notch receptors, VLA-4 integrin, and CXCR4, which, when integrated in an engineered platform, are sufficient to support the generation of engrafting HSCs. These studies provide a transcriptional map of the signaling interactions necessary for the development of HSCs and advance the goal of engineering HSCs for therapeutic applications.